Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

It looks like the SEC certainly helped Provista "dodge a bullet"

"Provista and Radient also are in merger talks. They signed an extension Sept. 27, 2010 to give Radient’s shareholders a chance to set a meeting date for approval. Radient is publicly traded and must abide by U.S. Sec-ur-ities and Exchange Commission regulations.

“They’ve been filing different reports, and their shareholder meeting keeps getting delayed,” Gartner said. “They have to respond to SEC comments. That’s the only thing that’s holding up their shareholder approval of our merger.”


Radient was attempting to get the PRE14A shareholder meeting material approved and could not justify the value they had placed on Jade. If Provista had in fact merged with Radient, they would be dead also.

http://www.bizjournals.com/phoenix/print-edition/2010/11/12/provista-developing-early-test.html?page=all